Business Description
Nipro Corp
ISIN : JP3673600007
Share Class Description:
FRA:5FA: Ordinary SharesDescription
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.14 | |||||
| Equity-to-Asset | 0.22 | |||||
| Debt-to-Equity | 2.58 | |||||
| Debt-to-EBITDA | 14.89 | |||||
| Interest Coverage | 3.02 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.01 | |||||
| Beneish M-Score | -2.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.5 | |||||
| 3-Year EBITDA Growth Rate | 5.3 | |||||
| 3-Year EPS without NRI Growth Rate | -22.8 | |||||
| 3-Year FCF Growth Rate | -0.7 | |||||
| 3-Year Book Growth Rate | 13.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 24.48 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.05 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 77.74 | |||||
| 9-Day RSI | 68.48 | |||||
| 14-Day RSI | 62.39 | |||||
| 6-1 Month Momentum % | 12.14 | |||||
| 12-1 Month Momentum % | 14.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.42 | |||||
| Quick Ratio | 0.79 | |||||
| Cash Ratio | 0.23 | |||||
| Days Inventory | 196.74 | |||||
| Days Sales Outstanding | 102.14 | |||||
| Days Payable | 69.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.96 | |||||
| Dividend Payout Ratio | 1.4 | |||||
| 3-Year Dividend Growth Rate | -2.5 | |||||
| Forward Dividend Yield % | 2.89 | |||||
| 5-Year Yield-on-Cost % | 2.23 | |||||
| Shareholder Yield % | -11.79 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.34 | |||||
| Operating Margin % | 3.64 | |||||
| Net Margin % | 0.21 | |||||
| FCF Margin % | 11.83 | |||||
| ROE % | 0.54 | |||||
| ROA % | 0.12 | |||||
| ROIC % | 1.07 | |||||
| ROC (Joel Greenblatt) % | 1.72 | |||||
| ROCE % | 1.75 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 228.89 | |||||
| Forward PE Ratio | 12.54 | |||||
| PE Ratio without NRI | 68.84 | |||||
| Shiller PE Ratio | 24.76 | |||||
| PEG Ratio | 7.25 | |||||
| PS Ratio | 0.42 | |||||
| PB Ratio | 0.87 | |||||
| Price-to-Tangible-Book | 1.05 | |||||
| Price-to-Free-Cash-Flow | 3.49 | |||||
| Price-to-Operating-Cash-Flow | 3.49 | |||||
| EV-to-EBIT | 62.86 | |||||
| EV-to-EBITDA | 18.44 | |||||
| EV-to-Revenue | 1.35 | |||||
| EV-to-FCF | 11.01 | |||||
| Price-to-Projected-FCF | 0.36 | |||||
| Price-to-DCF (Earnings Based) | 4.28 | |||||
| Price-to-DCF (FCF Based) | 0.21 | |||||
| Price-to-Median-PS-Value | 0.82 | |||||
| Price-to-Graham-Number | 1.82 | |||||
| Earnings Yield (Greenblatt) % | 1.6 | |||||
| FCF Yield % | 31.42 | |||||
| Forward Rate of Return (Yacktman) % | 30.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nipro Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3,785.734 | ||
| EPS (TTM) (€) | 0.034 | ||
| Beta | 0.11 | ||
| Volatility % | 17.06 | ||
| 14-Day RSI | 62.39 | ||
| 14-Day ATR (€) | 0.084167 | ||
| 20-Day SMA (€) | 8.0075 | ||
| 12-1 Month Momentum % | 14.6 | ||
| 52-Week Range (€) | 6.65 - 8.6 | ||
| Shares Outstanding (Mil) | 163.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nipro Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nipro Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nipro Corp Frequently Asked Questions
What is Nipro Corp(FRA:5FA)'s stock price today?
The current price of FRA:5FA is €8.30. The 52 week high of FRA:5FA is €8.60 and 52 week low is €6.65.
When is next earnings date of Nipro Corp(FRA:5FA)?
The next earnings date of Nipro Corp(FRA:5FA) is .
Does Nipro Corp(FRA:5FA) pay dividends? If so, how much?
The Dividend Yield %  of Nipro Corp(FRA:5FA) is 1.96% (As of Today), Highest Dividend Payout Ratio of Nipro Corp(FRA:5FA) was 1.4. The lowest was 0.2. And the median was 0.39. The  Forward Dividend Yield % of Nipro Corp(FRA:5FA) is 2.89%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers